Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
about
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
description
scientific article published on 01 January 2020
@en
name
Why Were More Than 200 Subject ...... Levothyroxine with an Old One?
@en
type
label
Why Were More Than 200 Subject ...... Levothyroxine with an Old One?
@en
prefLabel
Why Were More Than 200 Subject ...... Levothyroxine with an Old One?
@en
P2093
P50
P1476
Why Were More Than 200 Subject ...... Levothyroxine with an Old One?
@en
P2093
Aude A Ferran
Jean-Louis Montastruc
Peggy Gandia
Peter Lees
P356
10.1007/S40262-019-00812-X
P577
2020-01-01T00:00:00Z